Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87

被引:226
作者
Yu, Shi-cang [1 ]
Ping, Yi-fang [1 ]
Yi, Liang [1 ]
Zhou, Zhi-hua [1 ]
Chen, Han-hong [1 ]
Yao, Xiao-hong [1 ]
Gao, Lei [2 ]
Wang, Ji Ming [3 ]
Bian, Xiu-wu [1 ]
机构
[1] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 400037, Peoples R China
[3] Natl Canc Inst Frederick, Ctr Canc Res, Canc & Inflammat Program, Mol Immunoregulat Lab, Frederick, MD 21702 USA
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
cancer stem cells; glioblastoma; tumor spheres;
D O I
10.1016/j.canlet.2008.02.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A variety of malignant cancers have been found to contain a subpopulation of stem cell-like tumor cells, or cancer stem cells (CSCs). However, the existence of CSCs in U87, a most commonly used glioma cell line, is still controversial. In this study, we demonstrate that U87 cell line contained a fraction of tumor cells that could form tumor spheres and were enriched by progressively increasing the concentration of serum-free neural stem cell medium with or without low dose vincristine. These cells possessed the ability of self-renewal and multipotency, the defined characteristics of CSCs. Moreover, the tumors formed by the secondary spheres displayed typical histological features of human glioblastoma, including cellular pleomorphism, pseudopalisades surrounding necrosis, hyperchromatic nuclei, high density of microvessels and invasion to the brain parenchyma. These results indicate that gradually increasing the concentration of serum-free neural stem cell culture medium with or without vincristine is a simple and effective method for isolation of CSCs to study the initiation and progression of human glioblastoma. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:124 / 134
页数:11
相关论文
共 41 条
[1]   The root of the problem [J].
Abbott, Alison .
NATURE, 2006, 442 (7104) :742-743
[2]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[3]   Evolution of cancer stem cells [J].
Bapat, S. A. .
SEMINARS IN CANCER BIOLOGY, 2007, 17 (03) :204-213
[4]   Will cancer stem cells provide new therapeutic targets? [J].
Behbod, F ;
Rosen, JM .
CARCINOGENESIS, 2005, 26 (04) :703-711
[5]   Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? [J].
Bissell, MJ ;
LaBarge, MA .
CANCER CELL, 2005, 7 (01) :17-23
[6]   Apoptosis resistance can be used in screening the markers of cancer stem cells [J].
Chen Wei ;
Wang Guo-Min ;
Liu Yu-Jun .
MEDICAL HYPOTHESES, 2006, 67 (06) :1381-1383
[7]   Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line [J].
Christgen, Matthias ;
Ballmaier, Matthias ;
Bruchhardt, Henriette ;
von Wasielewski, Reinhard ;
Kreipe, Hans ;
Lehmann, Ulrich .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2007, 306 (1-2) :201-212
[8]  
Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
[9]   Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution [J].
Conrad, S ;
Kauffmann, HM ;
Ito, K ;
Deeley, RG ;
Cole, SPC ;
Schrenk, D .
JOURNAL OF HUMAN GENETICS, 2001, 46 (11) :656-663
[10]   Tumour stem cells and drug resistance [J].
Dean, M ;
Fojo, T ;
Bates, S .
NATURE REVIEWS CANCER, 2005, 5 (04) :275-284